PRACTITIONER 2009;253(1719):7
Weigh up the risks and benefits of IAD in prostate cancer
01 Jun 2009
This article can be accessed only if you are a paid-up subscriber to The Practitioner.
To subscribe contact: thepractitioner@servicehelpline.co.uk
Overseas subscription
Individual: £138Institutional: £138
Overseas: +44 (0)1795 418 670
Subscription enquiry: thepractitioner@servicehelpline.co.uk
UK subscription
Individual: £85Institutional: £85
UK: 0844 815 5934
Subscription enquiry: thepractitioner@servicehelpline.co.uk
= Registered users